LIFE – Lifecare ASA uplisting to Euronext Oslo Børs is approved
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Dagens aktierekar: BW LPG drar intresse till sig

Pressmeddelande

LIFE – Lifecare ASA uplisting to Euronext Oslo Børs is approved

MFN Publicerad: 21 Oct 17:27
Lifecare

Bergen, Norway, 21 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce that the company will transfer to Euronext Oslo Børs tomorrow 22 October 2024.

Reference is made to stock exchange announcement 27 September 2024 where it was announced that Oslo Børs has resolved to admit the shares of Lifecare ASA to trading on Oslo Børs. Today the commission at Euronext Oslo Børs approved Lifecare’s transfer from Euronext Growth to Euronext Oslo Børs.

- This is an important milestone for Lifecare to take the step to the regulated market Euronext Oslo Børs. On behalf of the entire organization, I am very proud that Oslo Børs' listing committee has assessed and concluded that Lifecare meets the conditions for admission to the main list. We have a proven the technology, we have focused on setting up production and we are now approaching our first product. Lifecare is now ready for the main list on Euronext Oslo Børs, says CEO Joacim Holter at Lifecare ASA.

Tuesday morning, 22 September 2024, Lifecare will ring the bell to mark the opening of the markets at Oslo Børs.

About us
Lifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's main focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on the sensor body for read-out of pressure variations. Lifecare's sensor technology is referred to as "Sencell" and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Renete Kaarvik, CFO, [email protected], +47 94 83 82 42

Attachments
LIFE – Lifecare ASA uplisting to Euronext Oslo Børs is approved

Bifogade filer

LIFE – Lifecare ASA uplisting to Euronext Oslo Børs is approvedhttps://storage.mfn.se/06904edd-4316-4309-b402-2a47aae622de/life-lifecare-asa-uplisting-to-euronext-oslo-bors-is-approved.pdf

Nyheter om Lifecare

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

Jämförelse: Vilken är Sveriges bästa fondrobot?Guide: Så börjar du spara i fonder som nybörjareTopplistor: Fonderna med bäst avkastning just nu
STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Lifecare

Senaste nytt